Prevention and treatment of coronary heart disease and its complications by Jean Lequime Excerpta Medica, Amsterdam, Netherlands (1980) 176 pages, many tables and illustrations $39.00 ISBN 0-444-90162-0

1982 ◽  
Vol 5 (1) ◽  
pp. 69-71
Author(s):  
R. A. Bruce
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Prevention And Treatment

scholarly journals Integrative Western and Chinese Medicine on Coronary Heart Disease: Where Is the Orientation?

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Siming Li ◽  
Hao Xu
Keyword(s):  
Coronary Heart Disease ◽  
Quality Control ◽  
Heart Disease ◽  
Integrative Medicine ◽  
Modern Medicine ◽  
Medicine Research ◽  
Prevention And Treatment ◽  
Fast Development ◽  
Original Innovation ◽  
Tcm Syndrome

Coronary heart disease (CHD) is the leading cause of death. As the main treatment of CHD, modern medicine has improved dramatically in recent years. Although researches of TCM and integrative medicine on CHD are witnessed encouraging progress in many respects, the role TCM playing in the prevention and treatment of CHD has been unprecedentedly challenged under such circumstance of the very fast development of modern medicine. In order to share mutual complementary advantages of TCM and western medicine, this review summarizes the relatively prominent researches of TCM and integrative medicine on CHD in recent years, and illuminates the issue of the orientation of the further research of integrative medicine on CHD, including (1) original innovation of TCM etiology and pathogenesis, (2) combination of disease and TCM syndrome, (3) biological basis of TCM syndrome of CHD, (4) clinical design and quality control of integrative medicine research, (5) herb-drug interaction, (6) difficulties and hot issues of modern medicine.

scholarly journals Prevention and Treatment of Coronary Heart Disease

Circulation ◽  
2001 ◽  
Vol 104 (14) ◽  
pp. 1688-1692 ◽  
Author(s):  
John C. LaRosa
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Prevention And Treatment

scholarly journals The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease

2018 ◽  
Vol 12 (3) ◽  
pp. 85-108 ◽  
Author(s):  
Mark Houston
Keyword(s):  
Risk Factors ◽  
Coronary Heart Disease ◽  
Body Composition ◽  
Heart Disease ◽  
Cardiovascular Risk ◽  
Structural Damage ◽  
Visceral Obesity ◽  
Prevention And Treatment ◽  
Cardiovascular Testing ◽  
Chd Risk Factors

Numerous clinical trials suggest that we have reached a limit in our ability to decrease the incidence of coronary heart disease (CHD) and cardiovascular disease (CVD) utilizing the traditional diagnostic evaluation, prevention and treatment strategies for the top five cardiovascular risk factors of hypertension, diabetes mellitus, dyslipidemia, obesity and smoking. About 80% of heart disease (heart attacks, angina, coronary heart disease and congestive heart failure) can be prevented by optimal nutrition, optimal exercise, optimal weight and body composition, mild alcohol intake and avoiding smoking. Statistics show that approximately 50% of patients continue to have CHD or myocardial infarction (MI) despite presently defined ‘normal’ levels of the five risk factors listed above. This is often referred to as the ‘CHD gap’. Novel and more accurate definitions and evaluations of these top five risk factors are required, such as 24 h ambulatory blood pressure (ABM) results, advanced lipid profiles, redefined fasting and 2 h dysglycemia parameters, a focus on visceral obesity and body composition and the effects of adipokines on cardiovascular risk. There are numerous traumatic insults from the environment that damage the cardiovascular system but there are only three finite vascular endothelial responses, which are inflammation, oxidative stress and immune vascular dysfunction. In addition, the concept of translational cardiovascular medicine is mandatory in order to correlate the myriad of CHD risk factors to the presence or absence of functional or structural damage to the vascular system, preclinical and clinical CHD. This can be accomplished by utilizing advanced and updated CV risk scoring systems, new and redefined CV risk factors and biomarkers, micronutrient testing, cardiovascular genetics, nutrigenomics, metabolomics, genetic expression testing and noninvasive cardiovascular testing.

Sign in / Sign up

Export Citation Format

Share Document